Our study did not provide evidence for defects in FoxP3+ Tregs in CTEPH patients, except that frequencies of CCR6+ Tregs were increased, allowing them to migrate towards inflamed tissues. This evidence concerns the gene CCR6 and chronic thromboembolic pulmonary hypertension.